Michelle Avery
Contatto Relazioni con gli Investitori presso PANDION THERAPEUTICS, INC.
Posizioni attive di Michelle Avery
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PANDION THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | 01/09/2020 | - |
Storia della carriera di Michelle Avery
Precedenti posizioni note di Michelle Avery
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Contatto Relazioni con gli Investitori | - | - |
| Public Communications Contact | - | - |
Statistiche
Distribuzione geografica
| Regno Unito | 2 |
| Stati Uniti | 2 |
Posizioni
| Investor Relations Contact | 2 |
| Public Communications Contact | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Pandion Therapeutics, Inc.
 Pandion Therapeutics, Inc. BiotechnologyHealth Technology Pandion Therapeutics, Inc. is a clinical stage biopharmaceutical company. It develops Therapeutic Autoimmune reguLatOry proteiN (TALON) drug design and discovery platform, which employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network. The company was founded by Dr. Joanne Viney on September 19, 2016 and is headquartered in Watertown, MA. | Health Technology |
- Borsa valori
- Insiders
- Michelle Avery
- Esperienza
